In thrombotic antiphospholipid syndrome, DOACs vs. VKAs increase arterial thrombotic events but not major bleeding.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 37011391.
- Also identified by DOI 10.7326/J23-0016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Khairani CD, Bejjani A, Piazza G, et al. <b>Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials.</b> J Am Coll Cardiol. 2023;81:16-30. 36328154.
Medical subject headings
- Antiphospholipid Syndrome
- Thrombosis